EUVIMEDEUVIMED entdecken
Crossref

Effect of Cobalamin Levels in Patients with T2DM Undergoing Metformin Therapy

Dr. V. P avithra, Dr. V. S. Kalaiselvi, Dr. B. Shanthi, Dr. K. Sumathi

International Journal of Drug Delivery Technology · 06.04.2026 · 16 (1)

DOI: 10.25258/ijddt.16.1.80 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 06.04.2026. Verfasst von Dr. V. P avithra und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low vitamin B12 concentrations are being documented more often in people living with T2DM. Metformin, still the first choice for glycaemic control, appears to be a major contributor to this trend. Although the link between metformin use and reduced Cobalamin levels is well supported, the extent to which dose, duration of therapy and individual patient factors shape this relationship varies across studies. Interpretation is made more difficult by the absence of a single, universally accepted cutoff for defining deficiency, which leads to wide differences in reported prevalence. Long-standing Cobalamin deficiency can result in neurological and haematological problems, making periodic evaluation of vitamin B12 status important for those at higher risk. Individuals following vegan diets while using metformin are particularly susceptible because their dietary intake of Cobalamin is limited. Lifestyle approaches that help maintain metabolic balance may also reduce the chance of developing nutritional deficiencies during extended treatment.

Zitieren

APA

avithra, D. V. P., Kalaiselvi, D. V. S., Shanthi, D. B., & Sumathi, D. K. (2026). Effect of Cobalamin Levels in Patients with T2DM Undergoing Metformin Therapy. International Journal of Drug Delivery Technology, 16(1). https://doi.org/10.25258/ijddt.16.1.80

Vancouver

avithra DVP, Kalaiselvi DVS, Shanthi DB, Sumathi DK. Effect of Cobalamin Levels in Patients with T2DM Undergoing Metformin Therapy. International Journal of Drug Delivery Technology. 2026;16(1). doi:10.25258/ijddt.16.1.80

BibTeX
@article{avithra2026,
  author = {avithra, Dr. V. P and Kalaiselvi, Dr. V. S. and Shanthi, Dr. B. and Sumathi, Dr. K.},
  title = {Effect of Cobalamin Levels in Patients with T2DM Undergoing Metformin Therapy},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.25258/ijddt.16.1.80}
}
Kostenlos starten →